A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)

Antibiotic resistance (AR) associated with chronic limb-threatening ischemia (CLTI) poses additional challenges for the management of ischemic leg ulcers, increasing the likelihood of severe outcomes. This study assessed AR prevalence in bacteria isolated from CLTI-associated leg ulcers before (1 Ja...

Full description

Bibliographic Details
Main Authors: Amaraporn Rerkasem, Pak Thaichana, Nuttida Bunsermvicha, Rawee Nopparatkailas, Supapong Arwon, Saranat Orrapin, Termpong Reanpang, Poon Apichartpiyakul, Saritphat Orrapin, Boonying Siribumrungwong, Nongkran Lumjuan, Kittipan Rerkasem, José G. B. Derraik
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/13/1/35
_version_ 1827372878942699520
author Amaraporn Rerkasem
Pak Thaichana
Nuttida Bunsermvicha
Rawee Nopparatkailas
Supapong Arwon
Saranat Orrapin
Termpong Reanpang
Poon Apichartpiyakul
Saritphat Orrapin
Boonying Siribumrungwong
Nongkran Lumjuan
Kittipan Rerkasem
José G. B. Derraik
author_facet Amaraporn Rerkasem
Pak Thaichana
Nuttida Bunsermvicha
Rawee Nopparatkailas
Supapong Arwon
Saranat Orrapin
Termpong Reanpang
Poon Apichartpiyakul
Saritphat Orrapin
Boonying Siribumrungwong
Nongkran Lumjuan
Kittipan Rerkasem
José G. B. Derraik
author_sort Amaraporn Rerkasem
collection DOAJ
description Antibiotic resistance (AR) associated with chronic limb-threatening ischemia (CLTI) poses additional challenges for the management of ischemic leg ulcers, increasing the likelihood of severe outcomes. This study assessed AR prevalence in bacteria isolated from CLTI-associated leg ulcers before (1 January 2017–10 March 2020; <i>n</i> = 69) and during (11 March 2020–31 December 2022; <i>n</i> = 59) the COVID-19 pandemic from patients admitted with positive wound cultures to a regional hospital in Chiang Mai (Thailand). There was a marked reduction in AR rates from 78% pre-pandemic to 42% during the pandemic (<i>p</i> < 0.0001), with rates of polymicrobial infections 22 percentage points lower (from 61% to 39%, respectively; <i>p</i> = 0.014). There were reduced AR rates to amoxicillin/clavulanate (from 42% to 4%; <i>p</i> < 0.0001) and ampicillin (from 16% to 2%; <i>p</i> = 0.017), as well as multidrug resistance (19% to 8%; <i>p</i> = 0.026). Factors associated with increased AR odds were polymicrobial infections (adjusted odds ratio (aOR) 5.6 (95% CI 2.1, 15.0); <i>p</i> = 0.001), gram-negative bacteria (aOR 7.0 (95% CI 2.4, 20.5); <i>p</i> < 0.001), and prior use of antibiotics (aOR 11.9 (95% CI 1.1, 128.2); <i>p</i> = 0.041). Improvements in infection control measures and hygiene practices in the community during the pandemic were likely key factors contributing to lower AR rates. Thus, strategic public health interventions, including community education on hygiene and the informed use of antibiotics, may be crucial in mitigating the challenges posed by AR in CLTI. Further, advocating for more judicious use of empirical antibiotics in clinical settings can balance effective treatment against AR development, thereby improving patient outcomes.
first_indexed 2024-03-08T11:07:26Z
format Article
id doaj.art-9a5e9c5d6c1f47fc8127b9eb7301e4c1
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-08T11:07:26Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-9a5e9c5d6c1f47fc8127b9eb7301e4c12024-01-26T14:36:53ZengMDPI AGAntibiotics2079-63822023-12-011313510.3390/antibiotics13010035A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)Amaraporn Rerkasem0Pak Thaichana1Nuttida Bunsermvicha2Rawee Nopparatkailas3Supapong Arwon4Saranat Orrapin5Termpong Reanpang6Poon Apichartpiyakul7Saritphat Orrapin8Boonying Siribumrungwong9Nongkran Lumjuan10Kittipan Rerkasem11José G. B. Derraik12Environmental-Occupational Health Sciences and Non-Communicable Diseases Research Center, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, ThailandEnvironmental-Occupational Health Sciences and Non-Communicable Diseases Research Center, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, ThailandClinical Surgical Research Center, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandDepartment of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandClinical Surgical Research Center, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandClinical Surgical Research Center, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandClinical Surgical Research Center, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandClinical Surgical Research Center, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, ThailandDepartment of Surgery, Faculty of Medicine, Thammasat University, Rangsit Campus, Pathum Thani 12120, ThailandDepartment of Surgery, Faculty of Medicine, Thammasat University, Rangsit Campus, Pathum Thani 12120, ThailandResearch Center for Molecular and Cell Biology, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, ThailandEnvironmental-Occupational Health Sciences and Non-Communicable Diseases Research Center, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, ThailandEnvironmental-Occupational Health Sciences and Non-Communicable Diseases Research Center, Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, ThailandAntibiotic resistance (AR) associated with chronic limb-threatening ischemia (CLTI) poses additional challenges for the management of ischemic leg ulcers, increasing the likelihood of severe outcomes. This study assessed AR prevalence in bacteria isolated from CLTI-associated leg ulcers before (1 January 2017–10 March 2020; <i>n</i> = 69) and during (11 March 2020–31 December 2022; <i>n</i> = 59) the COVID-19 pandemic from patients admitted with positive wound cultures to a regional hospital in Chiang Mai (Thailand). There was a marked reduction in AR rates from 78% pre-pandemic to 42% during the pandemic (<i>p</i> < 0.0001), with rates of polymicrobial infections 22 percentage points lower (from 61% to 39%, respectively; <i>p</i> = 0.014). There were reduced AR rates to amoxicillin/clavulanate (from 42% to 4%; <i>p</i> < 0.0001) and ampicillin (from 16% to 2%; <i>p</i> = 0.017), as well as multidrug resistance (19% to 8%; <i>p</i> = 0.026). Factors associated with increased AR odds were polymicrobial infections (adjusted odds ratio (aOR) 5.6 (95% CI 2.1, 15.0); <i>p</i> = 0.001), gram-negative bacteria (aOR 7.0 (95% CI 2.4, 20.5); <i>p</i> < 0.001), and prior use of antibiotics (aOR 11.9 (95% CI 1.1, 128.2); <i>p</i> = 0.041). Improvements in infection control measures and hygiene practices in the community during the pandemic were likely key factors contributing to lower AR rates. Thus, strategic public health interventions, including community education on hygiene and the informed use of antibiotics, may be crucial in mitigating the challenges posed by AR in CLTI. Further, advocating for more judicious use of empirical antibiotics in clinical settings can balance effective treatment against AR development, thereby improving patient outcomes.https://www.mdpi.com/2079-6382/13/1/35bacteriachronic limb-threatening ischemiacommunity healthischemic leg ulcerempirical antibiotic usegram-negative
spellingShingle Amaraporn Rerkasem
Pak Thaichana
Nuttida Bunsermvicha
Rawee Nopparatkailas
Supapong Arwon
Saranat Orrapin
Termpong Reanpang
Poon Apichartpiyakul
Saritphat Orrapin
Boonying Siribumrungwong
Nongkran Lumjuan
Kittipan Rerkasem
José G. B. Derraik
A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
Antibiotics
bacteria
chronic limb-threatening ischemia
community health
ischemic leg ulcer
empirical antibiotic use
gram-negative
title A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
title_full A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
title_fullStr A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
title_full_unstemmed A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
title_short A COVID-19 Silver Lining—Decline in Antibiotic Resistance in Ischemic Leg Ulcers during the Pandemic: A 6-Year Retrospective Study from a Regional Tertiary Hospital (2017–2022)
title_sort covid 19 silver lining decline in antibiotic resistance in ischemic leg ulcers during the pandemic a 6 year retrospective study from a regional tertiary hospital 2017 2022
topic bacteria
chronic limb-threatening ischemia
community health
ischemic leg ulcer
empirical antibiotic use
gram-negative
url https://www.mdpi.com/2079-6382/13/1/35
work_keys_str_mv AT amarapornrerkasem acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT pakthaichana acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT nuttidabunsermvicha acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT raweenopparatkailas acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT supapongarwon acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT saranatorrapin acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT termpongreanpang acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT poonapichartpiyakul acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT saritphatorrapin acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT boonyingsiribumrungwong acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT nongkranlumjuan acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT kittipanrerkasem acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT josegbderraik acovid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT amarapornrerkasem covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT pakthaichana covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT nuttidabunsermvicha covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT raweenopparatkailas covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT supapongarwon covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT saranatorrapin covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT termpongreanpang covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT poonapichartpiyakul covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT saritphatorrapin covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT boonyingsiribumrungwong covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT nongkranlumjuan covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT kittipanrerkasem covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022
AT josegbderraik covid19silverliningdeclineinantibioticresistanceinischemiclegulcersduringthepandemica6yearretrospectivestudyfromaregionaltertiaryhospital20172022